P/E ratio for Sientra (SIEN)
P/E ratio as of May 2024 (TTM): -0.0261
According to Sientra's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.0261261. At the end of 2022 the company had a P/E ratio of -0.1922.
P/E ratio history for Sientra from 2014 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -0.1922 | -94.03% |
| 2021 | -3.22 | 48.14% |
| 2020 | -2.17 | -28.05% |
| 2019 | -3.02 | -21.58% |
| 2018 | -3.85 | -8.51% |
| 2017 | -4.21 | 8.7% |
| 2016 | -3.87 | 58.96% |
| 2015 | -2.44 | -91.74% |
| 2014 | -29.5 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Edwards Lifesciences EW | 35.9 | -137,404.46% | 🇺🇸 USA |
 iRadimed IRMD | 36.2 | -138,685.17% | 🇺🇸 USA |
 Cardiovascular Systems CSII | -20.6 | 78,819.55% | 🇺🇸 USA |
 West Pharmaceutical WST | 48.4 | -185,327.80% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.